Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C, Chronic 1Hepatitis C 1Fibrosis 1Diabetes Mellitus 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1

Interventions

Magnetic Resonance Spectroscopy 3Blood Specimen Collection 3Specimen Handling 2Simvastatin 2Liver Transplantation 2tremelimumab 1sofosbuvir-velpatasvir drug combination 1epigallocatechin gallate 1durvalumab 1atezolizumab 1apixaban 1User-Centered Design 1Tocopherols 1Surveys and Questionnaires 1Standard of Care 1Sodium Chloride 1Sampling Studies 1Radiotherapy 1Radiation 1Pravastatin 1Phlebotomy 1Pharmaceutical Preparations 1Pentoxifylline 1Patient Navigation 1Neuropsychological Tests 1Musculoskeletal Manipulations 1Memantine 1Losartan 1Ketoprofen 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosis × sofosbuvir-velpatasvir drug combination × 1 year × Clear all
NCT03520660 2026-06-03

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

National Institutes of Health Clinical Center (CC)

Phase 4 Active not recruiting
121 enrolled
Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡